Business
Showing 1–16 of 77 results
| Title & Subtitle | Abstract | Contributors | Pages | Year | Purchase |
|---|---|---|---|---|---|
|
From  NEW! A Few Last Thoughts on Data and Decision MakingFrom: Shifting the Balance |
Afterword | Mark Schrutt | 7 | 2021 | $0.70 Add |
|
From  Academic health science centresresearch, money, controversies, conflict of interest and independence From: Doctors in Denial |
Describes and analyzes the money received by academic health science centres from the pharmaceutical industry for research and the conflicts that this money may create. | Joel Lexchin MD | 32 | 2017 | $3.20 Add |
|
From  NEW! At the Epicenter: Tobias LütkeFrom: The Shopify Story |
This chapter highlights Tobias Lütke’s early childhood and career as a computer programmer. | Larry MacDonald | 8 | 2024 | $0.80 Add |
|
From NEW! Big Data and Untapped InsightsFrom: Shifting the Balance |
Readings in part 1 of this text explore how companies combine intuition with data and analytics to drive competitive wedges in their markets. Topics in this chapter include the application of … | Mark Schrutt | 9 | 2021 | $0.90 Add |
|
From NEW! Big Data’s Role in Industry DisruptionFrom: Shifting the Balance |
Readings in part 2 of this text explore what it takes to be a data-driven organization that relies on facts and doesn’t make decisions based on instinct. Case studies included in this … | Mark Schrutt | 13 | 2021 | $1.30 Add |
|
From NEW! Blueprint for Data-driven OrganizationsFrom: Shifting the Balance |
Readings in part 4 of this text explore the ways in which data-driven decision making are applied to different industries | Mark Schrutt | 25 | 2021 | $2.50 Add |
|
From NEW! CEO of the YearFrom: The Shopify Story |
This chapter highlights Lütke’s leadership qualities and business strategies that helped increase Shopify’s growth. | Larry MacDonald | 7 | 2024 | $0.70 Add |
|
From  Clean Money EmergenceFrom: Clean Money Revolution |
Socially responsible investing (SRI) — rating and screening out the worst companies based on ethics and impacts — has been a major component of the shift to a generative economy. … | Joel Solomon; Tyee Bridge | 32 | 2017 | $3.20 Add |
|
From  Communication |
Strategic negotiators develop the skills, understanding and perspective to make considered and calculated choices about communication. Three forms of communication, the agent-principal … | David C. Dingwall | 37 | 2016 | $3.70 Add |
|
From NEW! COVID-19 at Warp SpeedFrom: The Shopify Story |
This chapter outlines how Shopify’s business was able to respond to the increase of new online businesses and shopping demands amidst the COVID-19 Pandemic. | Larry MacDonald | 9 | 2024 | $0.90 Add |
|
From NEW! Data’s Move to the FrontFrom: Shifting the Balance |
Readings in part 1 of this text explore how companies combine intuition with data and analytics to drive competitive wedges in their markets. This chapter discusses the emergence of technologies … | Mark Schrutt | 5 | 2021 | $0.50 Add |
|
From Demons for Negotiators |
The majority of difficulties that occur in a bargaining process arise out of errors made by the negotiators themselves which Dingwall breaks down into ego-creep, bias, neediness, naïve … | David C. Dingwall | 22 | 2016 | $2.20 Add |
Doctors in DenialWhy Big Pharma and the Canadian Medical Profession are Too Close for Comfort |
Examines the relationship between the Canadian medical profession and the pharmaceutical industry, and explains how doctors have become dependents of the drug companies instead of champions of … | 344 | View | ||
|
From Doctors, sales representatives, samples, gifts, trips and dinnersFrom: Doctors in Denial |
Discusses the various forms of interactions that pharmaceutical companies have with individual doctors in Canada, and how this impacts the health care they provide to their patients. | Joel Lexchin MD | 32 | 2017 | $3.20 Add |
|
From Don’t worry, be happy?From: Doctors in Denial |
Discusses whether patient care is negatively affected by the interactions that pharmaceutical companies have with the medical profession. | Joel Lexchin MD | 23 | 2017 | $2.30 Add |
|
From  NEW! DrugsRegulatory Capture and the Disabling of Drug Safety at Health Canada From: Corporate Rules |
In this chapter, Michèle Brill-Edwards provides a behind-the-scenes look at how the Canadian government has quietly disabled the safety system for drugs in Canada. The Food and Drugs Act … | Michèle Brill-Edwards | 23 | 2022 | $2.30 Add |
